Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 30, 2012 Filed Apr 3, 2012 21:05 UTC |
Warmuth Michael JSenior Vice President
|
Exercise / conversionCommon shares without par value | 6,146 | $54.05 | $332,191.30 |
DisclosureSEC source: 0001179110-12-006284 · edgar.xml · nonDerivative · entry 3 Warmuth Michael J · CIK 0001452290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,621 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 30, 2012 Filed Apr 3, 2012 21:05 UTC |
Warmuth Michael JSenior Vice President
|
Exercise / conversionCommon shares without par value | 2,649 | $57.93 | $153,456.57 |
DisclosureSEC source: 0001179110-12-006284 · edgar.xml · nonDerivative · entry 2 Warmuth Michael J · CIK 0001452290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,475 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 30, 2012 Filed Apr 3, 2012 21:05 UTC |
Warmuth Michael JSenior Vice President
|
Exercise / conversionCommon shares without par value | 4,540 | $54.03 | $245,296.20 |
DisclosureSEC source: 0001179110-12-006284 · edgar.xml · nonDerivative · entry 1 Warmuth Michael J · CIK 0001452290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,826 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 27, 2012 Filed Mar 29, 2012 21:04 UTC |
LINDER GREG WVice President
|
SaleCommon shares without par value | 29,331 | $61.35 | $1,799,456.85 |
DisclosureSEC source: 0001179110-12-005942 · edgar.xml · nonDerivative · entry 1 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,550 Read SEC document |
| March 22, 2012 Filed Mar 23, 2012 21:09 UTC |
Fussell Stephen RSenior Vice President
|
GrantOption (right to buy) · Derivative | 5,948 | $0.00 Strike: $60.39 | $0.00 |
DisclosureSEC source: 0001179110-12-005694 · edgar.xml · derivative · entry 8 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,948 Underlying: Common shares · 5,948 shares Expires 2013-02-13 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 22, 2012 Filed Mar 23, 2012 21:09 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 5,818 | $0.00 Strike: $47.82 | $0.00 |
DisclosureSEC source: 0001179110-12-005694 · edgar.xml · derivative · entry 7 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 5,818 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 22, 2012 Filed Mar 23, 2012 21:09 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 1,525 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001179110-12-005694 · edgar.xml · derivative · entry 6 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 1,525 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 22, 2012 Filed Mar 23, 2012 21:09 UTC |
Fussell Stephen RSenior Vice President
|
Tax withholdingCommon shares without par value | 5,948 | $60.39 | $359,199.72 |
DisclosureSEC source: 0001179110-12-005694 · edgar.xml · nonDerivative · entry 3 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,795 Read SEC document |
| March 22, 2012 Filed Mar 23, 2012 21:09 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionCommon shares without par value | 5,818 | $47.82 | $278,216.76 |
DisclosureSEC source: 0001179110-12-005694 · edgar.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,743 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 22, 2012 Filed Mar 23, 2012 21:09 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionCommon shares without par value | 1,525 | $33.23 | $50,677.89 |
DisclosureSEC source: 0001179110-12-005694 · edgar.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,925 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 22, 2012 Filed Mar 23, 2012 21:09 UTC |
LINDER GREG WVice President
|
Exercise / conversionOption (right to buy) · Derivative | 1,851 | $0.00 Strike: $54.74 | $0.00 |
DisclosureSEC source: 0001179110-12-005695 · edgar.xml · derivative · entry 27 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 1,851 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 22, 2012 Filed Mar 23, 2012 21:09 UTC |
LINDER GREG WVice President
|
Exercise / conversionOption (right to buy) · Derivative | 13,548 | $0.00 Strike: $58.71 | $0.00 |
DisclosureSEC source: 0001179110-12-005695 · edgar.xml · derivative · entry 26 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 13,548 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 22, 2012 Filed Mar 23, 2012 21:09 UTC |
LINDER GREG WVice President
|
Exercise / conversionOption (right to buy) · Derivative | 10,630 | $0.00 Strike: $56.30 | $0.00 |
DisclosureSEC source: 0001179110-12-005695 · edgar.xml · derivative · entry 25 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 10,630 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 22, 2012 Filed Mar 23, 2012 21:09 UTC |
LINDER GREG WVice President
|
Exercise / conversionOption (right to buy) · Derivative | 12,677 | $0.00 Strike: $52.55 | $0.00 |
DisclosureSEC source: 0001179110-12-005695 · edgar.xml · derivative · entry 24 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 12,677 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 22, 2012 Filed Mar 23, 2012 21:09 UTC |
LINDER GREG WVice President
|
SaleCommon shares without par value | 600 | $60.14 | $36,085.50 |
DisclosureSEC source: 0001179110-12-005695 · edgar.xml · nonDerivative · entry 22 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,881 Read SEC document |
| March 22, 2012 Filed Mar 23, 2012 21:09 UTC |
LINDER GREG WVice President
|
SaleCommon shares without par value | 1,100 | $60.14 | $66,154.00 |
DisclosureSEC source: 0001179110-12-005695 · edgar.xml · nonDerivative · entry 21 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,481 Read SEC document |
| March 22, 2012 Filed Mar 23, 2012 21:09 UTC |
LINDER GREG WVice President
|
SaleCommon shares without par value | 1,000 | $60.14 | $60,135.00 |
DisclosureSEC source: 0001179110-12-005695 · edgar.xml · nonDerivative · entry 20 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,581 Read SEC document |
| March 22, 2012 Filed Mar 23, 2012 21:09 UTC |
LINDER GREG WVice President
|
SaleCommon shares without par value | 2,000 | $60.13 | $120,260.00 |
DisclosureSEC source: 0001179110-12-005695 · edgar.xml · nonDerivative · entry 19 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,581 Read SEC document |
| March 22, 2012 Filed Mar 23, 2012 21:09 UTC |
LINDER GREG WVice President
|
SaleCommon shares without par value | 300 | $60.13 | $18,037.50 |
DisclosureSEC source: 0001179110-12-005695 · edgar.xml · nonDerivative · entry 18 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,581 Read SEC document |
| March 22, 2012 Filed Mar 23, 2012 21:09 UTC |
LINDER GREG WVice President
|
SaleCommon shares without par value | 2,572 | $60.12 | $154,628.64 |
DisclosureSEC source: 0001179110-12-005695 · edgar.xml · nonDerivative · entry 17 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,881 Read SEC document |
| March 22, 2012 Filed Mar 23, 2012 21:09 UTC |
LINDER GREG WVice President
|
SaleCommon shares without par value | 400 | $60.12 | $24,046.00 |
DisclosureSEC source: 0001179110-12-005695 · edgar.xml · nonDerivative · entry 16 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,453 Read SEC document |
| March 22, 2012 Filed Mar 23, 2012 21:09 UTC |
LINDER GREG WVice President
|
SaleCommon shares without par value | 3,584 | $60.11 | $215,434.24 |
DisclosureSEC source: 0001179110-12-005695 · edgar.xml · nonDerivative · entry 15 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,853 Read SEC document |
| March 22, 2012 Filed Mar 23, 2012 21:09 UTC |
LINDER GREG WVice President
|
SaleCommon shares without par value | 100 | $60.11 | $6,010.50 |
DisclosureSEC source: 0001179110-12-005695 · edgar.xml · nonDerivative · entry 14 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,437 Read SEC document |
| March 22, 2012 Filed Mar 23, 2012 21:09 UTC |
LINDER GREG WVice President
|
SaleCommon shares without par value | 18,942 | $60.10 | $1,138,414.20 |
DisclosureSEC source: 0001179110-12-005695 · edgar.xml · nonDerivative · entry 13 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,537 Read SEC document |
| March 22, 2012 Filed Mar 23, 2012 21:09 UTC |
LINDER GREG WVice President
|
SaleCommon shares without par value | 2,000 | $60.09 | $120,180.00 |
DisclosureSEC source: 0001179110-12-005695 · edgar.xml · nonDerivative · entry 12 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,479 Read SEC document |
| March 22, 2012 Filed Mar 23, 2012 21:09 UTC |
LINDER GREG WVice President
|
SaleCommon shares without par value | 300 | $60.09 | $18,025.50 |
DisclosureSEC source: 0001179110-12-005695 · edgar.xml · nonDerivative · entry 11 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,479 Read SEC document |
| March 22, 2012 Filed Mar 23, 2012 21:09 UTC |
LINDER GREG WVice President
|
SaleCommon shares without par value | 1,308 | $60.08 | $78,584.64 |
DisclosureSEC source: 0001179110-12-005695 · edgar.xml · nonDerivative · entry 10 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,779 Read SEC document |
| March 22, 2012 Filed Mar 23, 2012 21:09 UTC |
LINDER GREG WVice President
|
SaleCommon shares without par value | 200 | $60.08 | $12,015.00 |
DisclosureSEC source: 0001179110-12-005695 · edgar.xml · nonDerivative · entry 9 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,087 Read SEC document |
| March 22, 2012 Filed Mar 23, 2012 21:09 UTC |
LINDER GREG WVice President
|
SaleCommon shares without par value | 2,300 | $60.07 | $138,161.00 |
DisclosureSEC source: 0001179110-12-005695 · edgar.xml · nonDerivative · entry 8 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,287 Read SEC document |
| March 22, 2012 Filed Mar 23, 2012 21:09 UTC |
LINDER GREG WVice President
|
SaleCommon shares without par value | 400 | $60.07 | $24,026.00 |
DisclosureSEC source: 0001179110-12-005695 · edgar.xml · nonDerivative · entry 7 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,587 Read SEC document |
| March 22, 2012 Filed Mar 23, 2012 21:09 UTC |
LINDER GREG WVice President
|
SaleCommon shares without par value | 1,000 | $60.06 | $60,060.00 |
DisclosureSEC source: 0001179110-12-005695 · edgar.xml · nonDerivative · entry 6 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,987 Read SEC document |
| March 22, 2012 Filed Mar 23, 2012 21:09 UTC |
LINDER GREG WVice President
|
SaleCommon shares without par value | 600 | $60.06 | $36,033.00 |
DisclosureSEC source: 0001179110-12-005695 · edgar.xml · nonDerivative · entry 5 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,987 Read SEC document |
| March 22, 2012 Filed Mar 23, 2012 21:09 UTC |
LINDER GREG WVice President
|
Exercise / conversionCommon shares without par value | 1,851 | $54.74 | $101,323.74 |
DisclosureSEC source: 0001179110-12-005695 · edgar.xml · nonDerivative · entry 4 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,587 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 22, 2012 Filed Mar 23, 2012 21:09 UTC |
LINDER GREG WVice President
|
Exercise / conversionCommon shares without par value | 13,548 | $58.71 | $795,403.08 |
DisclosureSEC source: 0001179110-12-005695 · edgar.xml · nonDerivative · entry 3 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,736 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 22, 2012 Filed Mar 23, 2012 21:09 UTC |
LINDER GREG WVice President
|
Exercise / conversionCommon shares without par value | 10,630 | $56.30 | $598,469.00 |
DisclosureSEC source: 0001179110-12-005695 · edgar.xml · nonDerivative · entry 2 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,188 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 22, 2012 Filed Mar 23, 2012 21:09 UTC |
LINDER GREG WVice President
|
Exercise / conversionCommon shares without par value | 12,677 | $52.55 | $666,176.35 |
DisclosureSEC source: 0001179110-12-005695 · edgar.xml · nonDerivative · entry 1 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,558 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2012 Filed Mar 22, 2012 21:17 UTC |
ALBAN CARLOSSenior Vice President
|
SaleCommon shares without par value | 140 | $60.22 | $8,430.95 |
DisclosureSEC source: 0001179110-12-005623 · edgar.xml · nonDerivative · entry 3 ALBAN CARLOS · CIK 0001474632 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · Profit Sharing Trust (Puerto Rico) Disclosed balance after: 0 F1 · balance_after: Balance in the Abbott Laboratories Stock Retirement Trust as of March 20, 2012. Read SEC document |
| March 20, 2012 Filed Mar 22, 2012 21:17 UTC |
ALBAN CARLOSSenior Vice President
|
SaleCommon shares without par value | 684 | $60.22 | $41,191.23 |
DisclosureSEC source: 0001179110-12-005623 · edgar.xml · nonDerivative · entry 2 ALBAN CARLOS · CIK 0001474632 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · Profit Sharing Trust (U.S.) Disclosed balance after: 0 F1 · balance_after: Balance in the Abbott Laboratories Stock Retirement Trust as of March 20, 2012. Read SEC document |
| March 20, 2012 Filed Mar 22, 2012 21:17 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 25,701 | $0.00 Strike: $54.67 | $0.00 |
DisclosureSEC source: 0001179110-12-005621 · edgar.xml · derivative · entry 11 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 25,701 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 20, 2012 Filed Mar 22, 2012 21:17 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 26,572 | $0.00 Strike: $52.55 | $0.00 |
DisclosureSEC source: 0001179110-12-005621 · edgar.xml · derivative · entry 10 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 26,572 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 20, 2012 Filed Mar 22, 2012 21:17 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Tax withholdingCommon shares without par value | 24,314 | $60.22 | $1,464,189.08 |
DisclosureSEC source: 0001179110-12-005621 · edgar.xml · nonDerivative · entry 4 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 401,546 Read SEC document |
| March 20, 2012 Filed Mar 22, 2012 21:17 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Tax withholdingCommon shares without par value | 24,590 | $60.22 | $1,480,809.80 |
DisclosureSEC source: 0001179110-12-005621 · edgar.xml · nonDerivative · entry 3 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 425,860 Read SEC document |
| March 20, 2012 Filed Mar 22, 2012 21:17 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionCommon shares without par value | 25,701 | $54.67 | $1,405,073.67 |
DisclosureSEC source: 0001179110-12-005621 · edgar.xml · nonDerivative · entry 2 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,450 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2012 Filed Mar 22, 2012 21:17 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionCommon shares without par value | 26,572 | $52.55 | $1,396,358.60 |
DisclosureSEC source: 0001179110-12-005621 · edgar.xml · nonDerivative · entry 1 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 424,749 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 19, 2012 Filed Mar 21, 2012 21:04 UTC |
Landgraf John CExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 30,000 | $0.00 Strike: $44.16 | $0.00 |
DisclosureSEC source: 0001179110-12-005521 · edgar.xml · derivative · entry 4 Landgraf John C · CIK 0001298968 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,000 Underlying: Common shares · 30,000 shares Expires 2016-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 19, 2012 Filed Mar 21, 2012 21:04 UTC |
Landgraf John CExecutive Vice President
|
SaleCommon shares without par value | 30,000 | $60.00 | $1,800,000.00 |
DisclosureSEC source: 0001179110-12-005521 · edgar.xml · nonDerivative · entry 2 Landgraf John C · CIK 0001298968 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,145 Read SEC document |
| March 19, 2012 Filed Mar 21, 2012 21:04 UTC |
Landgraf John CExecutive Vice President
|
Exercise / conversionCommon shares without par value | 30,000 | $44.16 | $1,324,800.00 |
DisclosureSEC source: 0001179110-12-005521 · edgar.xml · nonDerivative · entry 1 Landgraf John C · CIK 0001298968 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,145 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 19, 2012 Filed Mar 21, 2012 21:04 UTC |
FULLER H LAURANCEDirector
|
Exercise / conversionOption (right to buy) · Derivative | 6,699 | $0.00 Strike: $41.20 | $0.00 |
DisclosureSEC source: 0001179110-12-005522 · edgar.xml · derivative · entry 11 FULLER H LAURANCE · CIK 0001187553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 6,699 shares Expires 2014-04-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 19, 2012 Filed Mar 21, 2012 21:04 UTC |
FULLER H LAURANCEDirector
|
Exercise / conversionOption (right to buy) · Derivative | 7,374 | $0.00 Strike: $37.42 | $0.00 |
DisclosureSEC source: 0001179110-12-005522 · edgar.xml · derivative · entry 10 FULLER H LAURANCE · CIK 0001187553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 7,374 shares Expires 2013-04-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 19, 2012 Filed Mar 21, 2012 21:04 UTC |
FULLER H LAURANCEDirector
|
Exercise / conversionOption (right to buy) · Derivative | 5,211 | $0.00 Strike: $50.65 | $0.00 |
DisclosureSEC source: 0001179110-12-005522 · edgar.xml · derivative · entry 9 FULLER H LAURANCE · CIK 0001187553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 5,211 shares Expires 2012-04-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.